Aspira Pathlab & Diagnostics Share Price

BSE
60.5
-1.30 (1.65%)
ASPIRA • 13 Jun, 2025 | 03:13 PM
BUY

1Y Annualised Return

105.38%

3Y Annualised Return

5.59%

5Y Annualised Return

11.18%

The current prices are delayed, login or Open Demat Account for live prices.

Aspira Pathlab & Diagnostics SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹1,15,34,301 (+77.45%)

Daily SIP of 25,000 would have become 1,15,34,301 in 1 year with a gain of 50,34,301 (+77.45%)

Aspira Pathlab & Diagnostics Stock Performance
Today’s Low - High
60.40
61.80
60.40
61.80
52 Week Low - High
25.00
106.78
25.00
106.78

Open

61.80

Prev. Close

61.80

Volume

168.00

Total Traded Value

10152.24

View details of Market Depth
Aspira Pathlab & Diagnostics Fundamental

Market Cap (in crs)

62.20

Face Value

10

Turnover (in lacs)

0.10

Key Metrics
Qtr Change %
43.41% Fall from 52W High
-28.1
Dividend yield 1yr %
0

Aspira Pathlab & Diagnostics Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Aspira Pathlab & Diagnostics Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024
5.78 Cr
5.41 Cr
6.18 Cr
4.64 Cr

Aspira Pathlab & Diagnostics Yearly Revenue

Mar 2025
22.39 Cr

Aspira Pathlab & Diagnostics Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024
0.72 Cr
0.31 Cr
0.99 Cr
-0.02 Cr

Aspira Pathlab & Diagnostics Yearly Net Profit/Loss

Mar 2025
2.07 Cr

Aspira Pathlab & Diagnostics shareholding Pattern

Promoter
18.4%
Public
81.6%
Promoter
18.6%
Public
81.5%
Promoter
18.6%
Public
81.5%
Promoter
18.7%
Public
81.3%
Promoter
18.7%
Public
81.3%
Promoter
18.9%
Public
81.1%

Aspira Pathlab & Diagnostics Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
60.5
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
59.10
10Day EMA
57.80
12Day EMA
57.60
20Day EMA
57.90
26Day EMA
58.60
50Day EMA
62.00
100Day EMA
64.30
200Day EMA
60.50
5Day SMA
58.60
10Day SMA
57.10
20Day SMA
56.60
30Day SMA
57.80
50Day SMA
61.80
100Day SMA
69.70
150Day SMA
68.70
200Day SMA
61.80
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
168 Rs
168 Rs
Week Rs
894 Rs
894 Rs
Month Rs
2337 Rs
2337 Rs
Resistance & Support
60.88
Pivot
Resistance
First Resistance
61.35
Second Resistance
62.28
Third Resistance
62.75
Support
First Support
59.95
Second support
59.48
Third Support
58.55
Relative Strength Index
53.26
Money Flow Index
41.52
MACD
-0.95
MACD Signal
-2.15
Average True Range
3.36
Average Directional Index
10.33
Rate of Change (21)
7.81
Rate of Change (125)
-10.80

Aspira Pathlab & Diagnostics Latest News

10 JUN 2025 | Tuesday

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication

09 JUN 2025 | Monday

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

02 JUN 2025 | Monday

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

View More

Aspira Pathlab & Diagnostics Company background

Founded in: 1973
Managing director: Pankaj Jashwant Shah
Aspira Pathlab Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with PanIndia presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year, the Company commenced its business activities of diagnostic center pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targeting newly setup hospitals and laboratory and trying to achieve more technology and advancement.

As of 13 Jun, 2025, ASPIRA share price is ₹60.4. The stock opened at ₹61.8 and had closed at ₹61.8 the previous day. During today’s trading session, ASPIRA share price moved between ₹60.40 and ₹61.80, with an average price for the day of ₹60.50. Over the last 52 weeks, the stock has recorded a low of ₹25.00 and a high of ₹106.78. In terms of performance, ASPIRA share price has declined by 10.4% over the past six months and has increased by 105.38% over the last year.

Read More

Aspira Pathlab & Diagnostics FAQs

You can easily buy Aspira Pathlab & Diagnostics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Aspira Pathlab & Diagnostics stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -